Full Press Release Details
MATERIAL CHANGE REPORT
| Item 1. | Name and Address of Company |
| Aurora Cannabis Inc. (" Aurora " or the " Company ") | |
| 500 - 10355 Jasper Avenue | |
| Edmonton, Alberta | |
| T5J 1Y6 | |
| Item 2. | Date of Material Change |
| November 14, 2018. | |
| Item 3. | News Release |
| A news release with respect to the material change referred to in this report was issued in Canada through the facilities of Canada Newswire and filed on SEDAR on November 14, 2018. | |
| Item 4. | Summary of Material Change |
| On November 14, 2018, the Company announced the appointment of Dr. Jonathan Page as Chief Science Officer. | |
| Item 5. | Full Description of Material Change |
| 5.1 Full Description of Material Change |
On November 14, 2018, the Company announced inter
appointment of Dr. Jonathan Page, PhD as the Company's Chief Science Officer.
In this new role, Dr. Page will oversee
all science-related projects at the Company. The Aurora science team develops innovative products for the medical, wellness and
adult consumer markets and focuses on delivering industry-leading cultivation results in terms of yields, consistency, quality
Dr. Page is a globally renowned cannabis
scientist, with 37 peer-reviewed publications, who was the co-lead of the Canadian team of scientists who first sequenced the cannabis
genome. His work also helped discover the biochemical pathways leading to the major cannabinoids. Prior to his appointment, Dr.
Page served as CEO of recently acquired Anandia Labs, the world-leading cannabis-focused science company he co-founded.
Aurora has ingrained scientific methods
throughout the Company, which it uses to drive efficiencies, medical and plant discovery and product innovation. That approach
will only increase with Dr. Page's appointment. With more than 40 PhD- and MSc-level researchers, Aurora has cutting-edge
research programs designed to develop competitive advantages.
An entrepreneurial scientist, Dr.
Page co-founded Anandia Labs, which specializes in cannabis genetics, metabolite profiling, plant breeding, disease characterization,
and cultivar certification, as well as providing third party independent testing services to producers and patient-cultivators.
Dr. Page is an adjunct professor in the Botany Department at the University of British Columbia (UBC) who received his PhD from
UBC, undertook postdoctoral training in Germany, and for a decade directed a lab at the National Research Council.
Dr. Page is also an accomplished
inventor with eight issued patents or patent applications, and a frequent lecturer on cannabis science at international conferences.
Anandia will continue to operate
independently of Aurora. Dr. John Coleman, PhD will be taking over as President at Anandia.
| 5.2 | Disclosure for Restructuring Transactions |
| Not applicable. | |
| Item 6. | Reliance on Subsection 7.1(2) of National Instrument 51-102 |
| Not applicable. | |
| Item 7. | Omitted Information |
| Not applicable. | |
| Item 8. | Executive Officer |
| The following senior officer of the Company is knowledgeable about the material change and this Material Change Report and may be contacted: | |
| Terry Booth, Chief Executive Officer (604) 362-5207 | |
| Item 9. | Date of Report |
| December 7, 2018 |